Compounds > losartan

losartan and thromboxanes

losartan has been researched along with thromboxanes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, RS; Chiu, AT; Leung, KH; Lotti, VJ; Roscoe, WA; Smith, RD; Timmermans, PB1
Goldenberg, HJ; Harris, DN; Hedberg, A; Liu, EC; Webb, ML1
Drenjancevic-Peric, I; Frisbee, JC; Lombard, JH; Phillips, SA1
Carranza, A; Mayer, MA; Peredo, HA; Puyó, AM1
Harris, NR; Lee, S1

Other Studies

5 other study(ies) available for losartan and thromboxanes

ArticleYear
AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    American journal of hypertension, 1992, Volume: 5, Issue:9

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Astrocytes; Biphenyl Compounds; Calcimycin; Cattle; Cells, Cultured; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Glioma; Imidazoles; Iodine Radioisotopes; Losartan; Macrophages; Male; Muscle, Smooth, Vascular; Prostaglandins; Pyridines; Radioimmunoassay; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Swine; Tetrazoles; Thromboxanes; Tumor Cells, Cultured

1992
DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors.
    Prostaglandins, 1992, Volume: 44, Issue:2

    Topics: Adrenal Cortex; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Cell Membrane; Humans; Imidazoles; Losartan; Membranes; Platelet Aggregation; Platelet Aggregation Inhibitors; Radioligand Assay; Rats; Receptors, Thromboxane; Tetrazoles; Thromboxanes

1992
Chronic AT(1) receptor blockade alters mechanisms mediating responses to hypoxia in rat skeletal muscle resistance arteries.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:2

    Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Cardiovascular Agents; Enzyme Inhibitors; Epoprostenol; Hypoxia; In Vitro Techniques; Indomethacin; Losartan; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Thromboxanes; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents

2004
Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Vessels; Dinoprostone; Drug Synergism; Epoprostenol; Fructose; Hemodynamics; In Vitro Techniques; Losartan; Male; Mesentery; Pioglitazone; PPAR gamma; Prostaglandins; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thromboxanes; Triglycerides

2008
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
    Microcirculation (New York, N.Y. : 1994), 2008, Volume: 15, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Blood Flow Velocity; Constriction, Pathologic; Female; Fibrinolytic Agents; Hyperglycemia; Losartan; Methacrylates; Mice; Mice, Inbred NOD; Retinal Vessels; Thromboxanes; Venules

2008